Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

Apr 2020| TBR520B| TBRC (Publisher)

Report Highlights

Including: By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs

By Type Of End-User: Asthma Patients; COPD Patients

By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral

Covering: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis

Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the demand for anti-asthmatics and COPD drugs market which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the anti-asthmatics and COPD drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-asthmatics and COPD drugs market opportunities and strategies to 2030: COVID 19 Implications and Growth report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  1. Executive Summary –The executive summary section of the report gives a brief overview and summary of the report.
  2. Report Structure – This section gives the structure of the report and the information covered in the various sections.
  3. Introduction -The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
  4. Market Characteristics –The market characteristics section of the report defines and explains the anti-asthmatics and COPD drugs market. This chapter includes different goods covered in the report and basic definitions.
  5. Supply Chain –The supply chain section of the report defines and explains the key players in the anti-asthmatics and COPD drugs industry supply chain.
  6. Product Analysis –The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  7. Top 10 Leading Drugs Sales–The section describes list of top 10 drugs and their sales in the anti-asthmatics and COPD drug market in 2019. It briefs on the drug chemical composition, drug class and the manufacturers involved in manufacturing and selling of these leading drugs in the anti-asthmatics and COPD drugs market.
  8. Patent Analysis Of Leading Drugs–The section briefs on the patent analysis of the leading drugs in the anti-asthmatics and COPD drugs market, by focusing on the leading drugs’ patent expiry and emergence of the generic drugs in the market.
  9. Customer Information– This chapter covers recent customers’ trends/preferences in the global anti-asthmatics and COPD drugs market.
  10. Impact Of COVID-19- This section describes the impact of COVID-19 on the anti-asthmatics and COPD drugs market.
  11. Trends And Strategies – This chapter describes the major trends shaping the global anti-asthmatics and COPD drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  12. Asthma And COPD Prevalence Overview–This section describes about asthma and COPD and their prevalence in the major countries.
  13. Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019 - 2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  14. Regional And Country Analysis – This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  15. Market Segmentation –This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments in the market.
  16. Regional Market Size And Growth–This section contains the region’s market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  17. Competitive Landscape – This section covers details on the competitive landscape of the global anti-asthmatics and COPD drugs market, estimated market shares and company profiles of the leading players.
  18. Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  19. Market Background – This section describes the respiratory diseases drugs market of which the anti-asthmatics and COPD drugs market is a segment. This chapter includes the respiratory diseases drugs market 2015-values, and regional analyses for the respiratory diseases drugs market.
  20. Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  21. Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-asthmatics and COPD drugs providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
  22. Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs

By Type Of End-User: Asthma Patients; COPD Patients

By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers

By Age Group: Below 5 Years; 5 to 14 Years; 15-69 Years; 70+ Years

By Type Of Therapy: Preventive; Curative

By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral

By Type Of Prescription: Prescription; OTC

By Type Of Drug: Branded; Generics

Companies Mentioned: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Russia, UK, Germany, France, Brazil.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Time series: Two five-year periods, one three-year period and one six-year period.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  • Table 2 : Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019
  • Table 3 : Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019
  • Table 4 : Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
  • Table 5 : Prevalence Of Asthma, 2014-2017
  • Table 6 : Prevalence Of COPD, 2014-2017
  • Table 7 : Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 8 : Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 9 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 10 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 12 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 13 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 14 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 15 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 16 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 17 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 18 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 19 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Table 20 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Table 21 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Table 22 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Table 23 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Table 24 : Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 25 : Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 26 : Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 27 : Air Pollution And Air Quality Index, Asia-Pacific Countries
  • Table 28 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 29 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 30 : Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 31 : Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 32 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 33 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 35 : China Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 36 : China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 37 : China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 38 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 39 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 40 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 41 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42 : India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 43 : India Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 44 : India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 45 : India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 46 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 47 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 49 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 50 : Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 51 : Japan Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 52 : Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 53 : Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 54 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 55 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 56 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 57 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 58 : Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 59 : Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 60 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 61 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 62 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 63 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64 : Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 65 : Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 66 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 67 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 69 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 70 : South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 71 : South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 72 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 73 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 74 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 75 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76 : Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 77 : Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 78 : Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 79 : Air Pollution And Air Quality Index in 2018, Western Europe Countries
  • Table 80 : Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 81 : Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 82 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 83 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 84 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 85 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86 : UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 87 : UK Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 88 : UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 89 : UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 90 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 91 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 92 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 93 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 94 : Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 95 : Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 96 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 97 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 98 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 99 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 100 : France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 101 : France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 102 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 103 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 104 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 105 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 106 : Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 107 : Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 108 : Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 109 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 110 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 111 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 112 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 113 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 114 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 115 : Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 116 : Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 117 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 118 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 119 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 120 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 121 : North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 122 : North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 123 : North America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 124 : North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 125 : North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 126 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 127 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 128 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 129 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 130 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 131 : USA Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 132 : USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 133 : USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 134 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 135 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 137 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 138 : South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 139 : South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 140 : South America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 141 : South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 142 : South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 143 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 144 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 145 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 146 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 147 : Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 148 : Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 149 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 150 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 151 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 152 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 153 : Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 154 : Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 155 : Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 156 : Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 157 : Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 158 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 159 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 161 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 162 : Africa Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 163 : Africa Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 164 : Africa Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 165 : Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 166 : Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 167 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 168 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 169 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 170 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 171 : Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 172 : GlaxoSmithKline - Financial Performance, 2015 - 2019, $ Billion
  • Table 173 : AstraZeneca plc. - Financial Performance2015 - 2019, $ Billion
  • Table 174 : Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion
  • Table 175 : F. Hoffmann-La Roche Ltd. - Financial Performance, 2015 - 2019, $ Billion
  • Table 176 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Table 177 : Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2023, $ Billion
  • Table 178 : Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Table 179 : Global Respiratory Diseases Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 180 : Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 181 : Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, Segmentation By Drug Class
  • Table 182 : Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Type Of End User
  • Table 183 : Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Distribution Channel
  • Table 184 : Anti-Asthmatics And COPD Drugs Market Data Sources
  • Figure 1 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
  • Figure 2 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
  • Figure 3 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
  • Figure 4 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
  • Figure 5 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
  • Figure 6 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
  • Figure 7 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
  • Figure 8 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
  • Figure 9 : Market Supply Chain For Anti-Asthmatics And COPD Drugs
  • Figure 10 : Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 11 : Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 12 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 13 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 14 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 15 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 16 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 17 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Figure 18 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Figure 19 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Figure 20 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Figure 21 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Figure 22 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 23 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 24 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 25 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26 : China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 27 : China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 28 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 30 : India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 31 : India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 32 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 33 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 34 : Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 35 : Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 36 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 37 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 38 : Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 39 : Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 40 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 41 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 42 : Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 43 : Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 44 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 45 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 46 : South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 47 : South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 48 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 49 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 50 : Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 51 : Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 52 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 53 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 54 : UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 55 : UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 56 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 57 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 58 : Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 59 : Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 60 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 61 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 62 : France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 63 : France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 64 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 65 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 66 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 67 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 68 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 69 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 70 : Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 71 : Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 72 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 73 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 74 : North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 75 : North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 76 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 77 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 78 : USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 79 : USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 80 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 81 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 82 : South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 83 : South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 84 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 85 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 86 : Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 87 : Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 88 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 89 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 90 : Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 91 : Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 92 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 93 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 94 : Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 95 : Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 96 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 97 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 98 : Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 99 : GlaxoSmithKline - Financial Performance, 2015 - 2019, $ Billion
  • Figure 100 : AstraZeneca plc. - Financial Performance2015 - 2019, $ Billion
  • Figure 101 : Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion
  • Figure 102 : F. Hoffmann-La Roche Ltd - Financial Performance, 2015 - 2019, $ Billion
  • Figure 103 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 104 : Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2023, $ Billion
  • Figure 105 : Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Figure 106 : Global Respiratory Diseases Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report